Oncology · Pain ManagementTrial Updateclinicalmid-term

Pilot Trial for Simulation-Free Celiac Plexus Pain Ablation Using SBRT Shows Novel Workflow

Importance7/ 10

ActionMonitor

AutoResearch

Multi-agent research across ingested FDA, EMA, MHRA, PMDA, PubMed, ClinicalTrials.gov, company documents, and Humanexa signals.

Last run 8/5/2026, 12:31:37 AM

Assessment confidence: 85% · The main uncertainty is whether clinical benefit translates into regulatory momentum and guideline influence.

Executive Thesis

The pilot trial for a simulation-free celiac plexus pain ablation workflow could significantly enhance treatment efficiency in oncology, potentially leading to improved patient outcomes and satisfaction. Pharma strategy teams should closely monitor the trial results, as successful implementation may influence treatment protocols and competitive positioning in pain management. Regulatory context from FDA (Expedited IND Pilot Program Educational Webinar for Stakeholders - 08/06/2026) supports the near-term read. Assessment grounded in 1 ranked evidence items (1 high-relevance).

Strategic Assessment

The strongest clinical anchor is Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial (ClinicalTrials.gov), weak alignment to signal sub-indication and entities. If the trial demonstrates a high success rate, it could lead to increased adoption of this workflow, impacting market share for companies involved in oncology and pain management therapies.

Competitive Pressure

The most relevant competitive pressure comes from If successful, this approach could streamline treatment delivery, potentially enhancing patient throughput and satisfaction in oncology settings..

Regulatory Outlook

Regulatory outlook for patients with cancer-related celiac pain is limited by sparse ingested precedent data.

Key Risks

Evidence gap: no medium- or high-relevance regulatory precedents in ingested corpus.

Key Opportunities

If the trial demonstrates a high success rate, it could lead to increased adoption of this workflow, impacting market share for companies involved in oncology and pain management therapies.
The implications of adopting novel treatment workflows that improve efficiency and patient outcomes in pain management.

What Would Change This Assessment

This becomes more urgent if Monitor trial results for patient outcomes and workflow efficiency metrics, particularly the 80% success rate in the first treatment attempt.
Timeline shift beyond mid term would change urgency.
A competitor label expansion or pivotal readout in the same sub-indication would increase competitive pressure.

Supporting Evidence

Expedited IND Pilot Program Educational Webinar for Stakeholders - 08/06/2026
FDAlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source
Guidance Snapshot Pilot
FDAlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
ClinicalTrials.govlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source
A Clinical Trial to Investigate the Efficacy and Safety of Plant-derived Cetylated Fatty Acids (CFA) on Knee Pain and Stiffness in Healthy Adults With Persistent Knee Pain
ClinicalTrials.govlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source
Global Myofascial Treatment With Focused Shockwave for Non-Specific Low Back Pain: Randomized Control Trial.
ClinicalTrials.govlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source
A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized Sedation
ClinicalTrials.govlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source
Effect of Thread-Embedding Acupuncture at EX-B2 Acupoint on Pain Intensity and Quality of Life in Chronic Low Back Pain
ClinicalTrials.govlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source
Effect of Dry Needling Plus Vibration on Myofascial Trigger Points in Individuals With Nonspecific Low Back Pain
ClinicalTrials.govlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source
Effects of Different Myofascial Release Techniques on Function in Chronic Non-Specific Neck Pain
ClinicalTrials.govlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source

[Ad hoc announcement pursuant to Art.
Rochelow relevance
Sponsor/company relevance (Roche)
FDA document
View source
[Ad hoc announcement pursuant to Art.
Rochelow relevance
Sponsor/company relevance (Roche)
FDA document
View source
[Ad hoc announcement pursuant to Art.
Rochelow relevance
Sponsor/company relevance (Roche)
FDA document
View source
Roche receives CE Mark for blood test to identify tuberculosis infection
Rochelow relevance
Sponsor/company relevance (Roche)
FDA document
View source
Roche receives CE Mark for blood test to identify tuberculosis infection
Rochelow relevance
Sponsor/company relevance (Roche)
FDA document
View source
Study on Multivirus CTL for Viral Infections Post Allogeneic SCT Shows Promise
Humanexa Signalslow relevance
Weak alignment to signal sub-indication and entities

Effect of transcutaneous auricular vagus nerve stimulation on postoperative pain in patients undergoing thoracoscopic partial lung resection: a randomized, double-blind, controlled clinical trial.
PubMedhigh relevance
Sub-indication match (pain)
FDA document
View source
Effects of blood-flow velocity and direction on coagulation zone symmetry induced by microwave ablation using ECO antenna.
PubMedlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source
Effects of acute HMB-FA supplementation on antioxidant status and muscle damage in Elite Judoka: a randomized pilot trial.
PubMedlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source
Client and therapist experiences with the Processing of Positive Memories Technique (PPMT) in a randomized controlled trial: insights for protocol refinement.
PubMedlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source
Effect of oral calcium carbonate on uterine contractility: a pilot randomised controlled trial.
PubMedlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source
Rotation-traction manipulation versus cervical traction for axial neck pain caused by cervical degenerative disc disease: a multicenter randomized controlled trial.
PubMedlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source
Immunogenicity and safety of a 2 + 1 schedule of the DTaP-IPV-HB-Hib hexavalent combination vaccine in preterm infants in Spain.
PubMedlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View source

Regunera

Precedents · guidance

Reg

Loading regulatory precedents…

View full regulatory analysis

Competitiva

Competitors · threats

Intel

Loading competitive findings…

View full competitive analysis

Why this matters

Affected entities

patients with cancer-related celiac pain

Commercial impact

medium

If the trial demonstrates a high success rate, it could lead to increased adoption of this workflow, impacting market share for companies involved in oncology and pain management therapies.

Regulatory impact

low

As the treatment itself is standard-of-care, regulatory implications are minimal; however, novel workflows may require future considerations for guidelines.

What to watch

Monitor trial results for patient outcomes and workflow efficiency metrics, particularly the 80% success rate in the first treatment attempt.

Recommended action

Monitor

Track for follow-up milestones; no immediate action required.